Diseases & Conditions Market Research Reports & Industry Analysis
Insomnia is a common condition in which one has trouble going to sleep or staying asleep. This condition can range from weak to strong, depending on how often it occurs and for how long. Insomnia can be ongoing or acute. Chronic insomnia means having symptoms at least 3 nights a week for more than a month. Acute insomnia lasts for less time. Some people who have insomnia will have trouble falling asleep. Other people may fall asleep easily but, then wake up.
Diseases & Conditions Industry Research & Market Reports
-
2024 Global Cancer Supportive Care Drugs Industry (2030 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include ... Read More
-
Pulmonary Arterial Hypertension
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Prostacyclin & Prostacyclin Analogs, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$5.3 ... Read More
-
Relapsing-Remitting Multiple Sclerosis - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Acute Ocular Pain And Inflammation - Pipeline Insight, 2024
... growth prospects across the Acute Ocular Pain And Inflammation market. A detailed picture of the Acute Ocular Pain And Inflammation pipeline landscape is provided, which includes the disease overview and Acute Ocular Pain And Inflammation ... Read More
-
CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2024
... Therapy for Multiple Myeloma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It ... Read More
-
Malaria - Pipeline Insight, 2024
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Malaria Understanding ... Read More
-
Advanced Renal Cell Carcinoma- Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
HER2 Negative Breast Cancer- Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
Celiac Disease- Pipeline Insight, 2024
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Celiac ... Read More
-
Unresectable Melanoma - Pipeline Insight, 2024
... picture of the Unresectable Melanoma pipeline landscape is provided, which includes the disease overview and Unresectable Melanoma treatment guidelines. The assessment part of the report embraces in-depth Unresectable Melanoma commercial assessment and clinical assessment of ... Read More
-
2024 Global Cancer Immunotherapy Industry (2030 Outlook)
... reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total value of ... Read More
-
Hemophilia A - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Genital Herpes - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Next Generation Sequencing Market By PRODUCT (Consumables, Platforms, Services), By APPLICATION (Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized medicine, Agriculture and animal research, Others), By TECHNOLOGY (Sequencing By synthesis (SBS), Ion semiconductor sequencing (IOS), Sequencing By Ligation (SBL), Pyrosequencing, Single-molecule-real-time sequencing (SMRT), Others), By END USER (Academic and clinical research centers, Pharmaceutical and biotechnology companies, Hospitals and clinics, Others): Global Opportunity Analysis and Industry Forecast, 2024-2035
... By Ligation (SBL), Pyrosequencing, Single-molecule-real-time sequencing (SMRT), Others), By END USER (Academic and clinical research centers, Pharmaceutical and biotechnology companies, Hospitals and clinics, Others): Global Opportunity Analysis and Industry Forecast, 2024-2035 The next generation sequencing ... Read More
-
Live Attenuated Vaccines Market - By Vaccine Type (Bacterial, Viral), Development (Tissue Culture, Embryonated Eggs, Live Animals), Age Group, Mode of Administration, Indication (Tuberculosis, Measles, Rotavirus), End-use - Global Forecast (2024 Â 2032)
... vaccines market will witness 10.4% CAGR from 2024 to 2032. The long-term protection provided by live vaccines against diseases has led to their widespread use besides their ability to stimulate a strong immune response, further ... Read More
-
Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2024
... the Acute Lymphoblastic Leukemia (ALL) market. A detailed picture of the Acute Lymphoblastic Leukemia (ALL) pipeline landscape is provided, which includes the disease overview and Acute Lymphoblastic Leukemia (ALL) treatment guidelines. The assessment part of ... Read More
-
Radiopharmaceuticals Market By End User (Hospitals and Clinics, Medical Imaging Centers, Others), By Radioisotope (Technetium 99m, Gallium 68, Iodine I, Fluorine 18, Copper 64, Strontium 89, Yttrium 90, Radium 223, Actinium 225, Lutetium 177, Copper 67, Terbium 161, Zirconium 89, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic): Global Opportunity Analysis and Industry Forecast, 2024-2033
... 67, Terbium 161, Zirconium 89, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic): Global Opportunity Analysis and Industry Forecast, 2024-2033 The radiopharmaceuticals market was valued at $7.9 billion in 2023 and is estimated ... Read More
-
Autoimmune Gastritis - Pipeline Insight, 2024
... picture of the Autoimmune Gastritis pipeline landscape is provided, which includes the disease overview and Autoimmune Gastritis treatment guidelines. The assessment part of the report embraces in-depth Autoimmune Gastritis commercial assessment and clinical assessment of ... Read More
-
Autoimmune Hepatitis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Lyme Disease - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Non-Radiographic Axial Spondyloarthritis (nrAxSpA) - Pipeline Insight, 2024
... the Non-Radiographic Axial Spondyloarthritis (nrAxSpA) market. A detailed picture of the Non-Radiographic Axial Spondyloarthritis (nrAxSpA) pipeline landscape is provided, which includes the disease overview and Non-Radiographic Axial Spondyloarthritis (nrAxSpA) treatment guidelines. The assessment part of ... Read More
-
Autoimmune pulmonary alveolar proteinosis (aPAP) - Pipeline Insight, 2024
... growth prospects across the Autoimmune pulmonary alveolar proteinosis (aPAP) market. A detailed picture of the Autoimmune pulmonary alveolar proteinosis (aPAP) pipeline landscape is provided, which includes the disease overview and Autoimmune pulmonary alveolar proteinosis (aPAP) ... Read More
-
Autoimmune Encephalitis (AE) - Pipeline Insight, 2024
... (AE) market. A detailed picture of the Autoimmune Encephalitis (AE) pipeline landscape is provided, which includes the disease overview and Autoimmune Encephalitis (AE) treatment guidelines. The assessment part of the report embraces in-depth Autoimmune Encephalitis ... Read More
-
Human Insulin Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... 19.19 billion in 2023, and the market is now projected to grow from USD 19.69 billion in 2024 to USD 25.08 billion by 2032, exhibiting a CAGR of 3.1% during the forecast period of 2023-2032. ... Read More
-
Bladder Pain - Pipeline Insight, 2024
... picture of the Bladder Pain pipeline landscape is provided, which includes the disease overview and Bladder Pain treatment guidelines. The assessment part of the report embraces in-depth Bladder Pain commercial assessment and clinical assessment of ... Read More
Research Assistance
